Abstract:Clinical nonspecific cold and heat stimulation induces upper airway hyperresponsiveness in patients without allergens, aggravates relevant symptoms in patients with AR, and the treatment effect of relying on existing immune drugs is poor. The above problems persist in clinic, but there is no effective solution. The discovery of transient receptor potential (TRP) in upper airway hyperresponsiveness disease (AHR) provides a new idea. Neuroimmune pathway is an important component of the pathogenesis of AHR. The expression and stimulation of TRP are closely related to it. Relevant research will eventually solve the mystery of the specific pathogenesis of such symptoms and become a new direction of clinical treatment and intervention in the future. This review highlights the key components of the neuroimmune pathway pathogenesis of AHR and the role of related TRP channels, and TRPV1, TRPA1 are gradually entering the clinic, TRPV4, TRPM8 are expected to become a new focus of drug research